These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8083102

  • 1. A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer.
    Scarantino CW, McCunniff AJ, Evans G, Young CW, Paggiarino DA.
    Int J Radiat Oncol Biol Phys; 1994 Jul 30; 29(5):999-1004. PubMed ID: 8083102
    [Abstract] [Full Text] [Related]

  • 2. Radiotherapy plus lonidamine in non-small cell lung cancer.
    Cionini L.
    Semin Oncol; 1991 Apr 30; 18(2 Suppl 4):49-52. PubMed ID: 1851578
    [Abstract] [Full Text] [Related]

  • 3. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U, Cavalli F, Häussinger K, Kaukel E, Koschel G, Martinelli G, Neuhauss R, von Pawel J.
    Semin Oncol; 1991 Apr 30; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [Abstract] [Full Text] [Related]

  • 4. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
    Privitera G, Ciottoli GB, Patanè C, Palmucci T, Tafuri G, Marletta F, De Luca B, Magnani F, De Gregorio M, Greco S.
    Radiother Oncol; 1987 Dec 30; 10(4):285-90. PubMed ID: 3444905
    [Abstract] [Full Text] [Related]

  • 5. Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer.
    Magno L, Terraneo F, Bertoni F, Tordiglione M, Bardelli D, Rosignoli MT, Ciottoli GB.
    Int J Radiat Oncol Biol Phys; 1994 Apr 30; 29(1):45-55. PubMed ID: 8175445
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
    Filipazzi V, Cattaneo MT, Rho B, Frontini L, D'Adda D, Isa L, Scapaticci R, Legnani W, Calzavara MP, Berni F.
    Oncology; 1993 Apr 30; 50(1):10-3. PubMed ID: 8380632
    [Abstract] [Full Text] [Related]

  • 7. The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force.
    De Marinis F, Rinaldi M, Ardizzoni A, Bruzzi P, Pennucci MC, Portalone L, D'Aprile M, Ripanti P, Romano F, Belli M, Altavilla G, Migliorino MR, Rosso R, Salvati F.
    Tumori; 1999 Apr 30; 85(3):177-82. PubMed ID: 10426128
    [Abstract] [Full Text] [Related]

  • 8. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
    Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW.
    Int J Radiat Oncol Biol Phys; 1997 Apr 01; 38(1):149-55. PubMed ID: 9212017
    [Abstract] [Full Text] [Related]

  • 9. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
    Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT.
    Int J Radiat Oncol Biol Phys; 2002 Apr 01; 52(5):1173-9. PubMed ID: 11955727
    [Abstract] [Full Text] [Related]

  • 10. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):343-50. PubMed ID: 8635942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA, McGinnis WL, Stella PJ, Marschke RF, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA.
    Cancer; 1998 Mar 15; 82(6):1037-48. PubMed ID: 9506347
    [Abstract] [Full Text] [Related]

  • 13. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
    Cicenas S, Zaliene A, Atkocius V.
    Medicina (Kaunas); 2009 Jun 01; 45(6):452-9. PubMed ID: 19605965
    [Abstract] [Full Text] [Related]

  • 16. Single-agent paclitaxel and radiation for non-small cell lung cancer.
    Akerley W, Choy H.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):85-9. PubMed ID: 10210545
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
    Ianniello GP, De Cataldis G, Comella P, Scarpati MD, Maiorino A, Brancaccio L, Cioffi R, Lombardi A, Carnicelli P, Tinessa V.
    Cancer; 1996 Jul 01; 78(1):63-9. PubMed ID: 8646728
    [Abstract] [Full Text] [Related]

  • 20. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
    Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T, Cole B, Kennedy T.
    J Clin Oncol; 1998 Oct 01; 16(10):3316-22. PubMed ID: 9779707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.